Frank Steven bought BCRX
February 27, 2026 · Form 4 insider transaction
Frank Steven bought 1,285 shares of BioCryst Pharmaceuticals, Inc. at $8.75 per share, a transaction worth $11.2K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,285
Price
$8.75
Total value
$11.2K
InsiderFrank Steven
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after18,903
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $11,250.